18F-FDG PET/CT for initial staging in a 68-year-old man with moderately differentiated adenocarcinoma of the rectum showed intense FDG uptake in the primary site in the rectum (Fig. 1B,C yellow arrow) and mild to moderate heterogeneous FDG uptake in diffuse sclerotic lesions involving the left hemipelvis, proximal aspects of left femur, and L5 vertebra (Fig. 1A, red arrow, Fig. 1D,E). Incidentally, per rectal examination revealed a hard nodule in the right half of the prostate and his serum prostate-specific antigen (sPSA) level was elevated (11 ng/mL). Subsequent biopsy revealed adenocarcinoma of the prostate (Gleason score – 7), and a 68Ga PSMA PET/CT for initial staging showed intense tracer uptake in the primary site in the prostate (Fig. 1F,J green arrow) and mild to moderate heterogeneous tracer uptake in the bone lesions (Fig. 1G-I, red arrow) similar to that seen in 18F-FDG PET/CT. As the pattern was not definitive for bone metastases from either the rectum or prostate, a bone biopsy from the left iliac crest was done, which revealed Paget’s disease. The role of 18F-FDG PET/CT in colorectal cancer [1] and 68Ga PSMA PET/CT in prostate cancer is well established [2]. False positive uptake in Paget’s disease in 18F-FDG PET/CT [3] and 68Ga PSMA PET/CT is published [4]. This case reinforces the fact that atypical findings on PET/CT warrant careful interpretation and often histopathological correlation.